1. Home
  2. CPSH vs IFRX Comparison

CPSH vs IFRX Comparison

Compare CPSH & IFRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CPS Technologies Corp.

CPSH

CPS Technologies Corp.

HOLD

Current Price

$4.46

Market Cap

67.6M

ML Signal

HOLD

Logo InflaRx N.V.

IFRX

InflaRx N.V.

HOLD

Current Price

$0.93

Market Cap

60.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CPSH
IFRX
Founded
1984
2007
Country
United States
Germany
Employees
N/A
N/A
Industry
Building Materials
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
67.6M
60.6M
IPO Year
1995
2017

Fundamental Metrics

Financial Performance
Metric
CPSH
IFRX
Price
$4.46
$0.93
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
6
Target Price
$6.00
$8.50
AVG Volume (30 Days)
362.6K
342.3K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.03
N/A
Revenue
N/A
N/A
Revenue This Year
$55.87
N/A
Revenue Next Year
$19.98
$1,054.36
P/E Ratio
$149.00
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.40
$0.71
52 Week High
$6.85
$1.94

Technical Indicators

Market Signals
Indicator
CPSH
IFRX
Relative Strength Index (RSI) 46.06 51.84
Support Level $4.36 $0.73
Resistance Level $4.89 $1.16
Average True Range (ATR) 0.37 0.05
MACD -0.10 0.02
Stochastic Oscillator 26.70 83.32

Price Performance

Historical Comparison
CPSH
IFRX

About CPSH CPS Technologies Corp.

CPS Technologies Corp provides material solutions to the transportation, automotive, energy, computing/Internet, telecommunications, aerospace, defense, and oil and gas end markets. Its primary material solution is metal matrix composites (MMCs), which are a class of materials consisting of a combination of metal and ceramic. The company designs, manufactures and sells custom MMC components, which manages the performance and reliability of systems in the end markets. It also provides baseplates and housings used in radar, satellite and avionics applications. The company provides lids and heat spreaders used with integrated circuits in Internet switches and routers.

About IFRX InflaRx N.V.

InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent, and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.

Share on Social Networks: